GenScript's Solution for Advancing the Development of CRISPR Gene Therapy with Live Q&A

In the past decade, gene editing has been increasingly emphasized as an essential tool for therapy development. This has led to significant scientific advances in understanding disease mechanisms and developing novel, effective, and safe therapeutic interventions. GenScript offers a wide selection of services and products, enabling CRISPR gene editing for Therapy Development. In this webinar, we will review the options for sgRNA synthesis, HDR knock-in templates, and delivery methodologies and discuss the advantages and disadvantages of each one. And we will also provide an introduction to the GenScript's GMP grade CRISPR reagents capacity. Join us to learn how GenScript’s comprehensive solutions for CRISPR gene editing will enhance your research and therapy development workflows.